Global Psoriasis Therapeutics Market 2015-2019
-
Upload
technavio -
Category
Healthcare
-
view
166 -
download
0
Transcript of Global Psoriasis Therapeutics Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
Global Psoriasis Therapeutics Market 2015-2019
• The report discusses the following in-depth:
• Market Segmentation by Product
• Market Segmentation by Nature of Transaction
• Demographic Segmentation
• Service Segmentation
• Business Segmentation by Revenue
• Geographical Segmentation by Revenue
For more information on the
Global Psoriasis Therapeutics Market 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Trends
TechNavio’s senior analyst says, “The Global Psoriasis Therapeutics market is driven by several factors. Growing unmet needs in terms of the availability of appropriate drugs is one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely, and the drugs have a low safety profile.”
• Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes a buildup of thick white, red, or silvery patches of skin. It alters the normal cell cycle of the skin. The new skin cells grow and move quickly to the surface of the skin to form patches known as "plaques".
• The Global Psoriasis Therapeutics market is expected to grow at a high rate, posting a CAGR of 9.95 percent during the period 2014-2019.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Enabling technologies and the roadmap
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge and trend is available
in our report:
Global Psoriasis Therapeutics Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
Vendors Landscape
For a full list of vendors view our report,
Global Psoriasis Therapeutics Market 2015-2019
AbbVie Inc.
Amgen Inc.
Janssen Pharmaceuticals Inc.
AbbVie is a major player in the Global Psoriasis Therapeutics market. AbbVieis a biopharmaceutical company that focuses mainly on the development, manufacture, and marketing of pharmaceutical products globally.
Amgen is an important player in the Global Psoriasis Therapeutics market. It is a biotechnology-based company that is involved in the discovery, development, manufacturing, and delivery of human therapeutics in various areas such as oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine globally.
Janssen Pharmaceuticals is another major player in the Global Psoriasis Therapeutics market. It is a pharmaceutical company of Johnson & Johnson that manufactures medications for a wide range of diseases in areas such as immunology, neurology, mental health, pain management, and women's health.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The Global Psoriasis Therapeutics market is expected to grow at a rapid pace during the forecast period.
• This growth is expected to be the result of unmet needs coupled with the launch of novel pipeline drug candidates.
• An increase in the prevalence of psoriasis along with an increase in public awareness and the availability of diagnostic tools are also expected to drive the market during the forecast period. Factors such as high cost of therapy, adverse effects of drugs used, and use of CAM are likely to hinder the growth of the market in the future.
• The market is expected to witness certain trends such as dominance of the market by various biologics, an overall increase in public awareness about the disease, and growing popularity of generics and off-label drugs.
• The Global Psoriasis Therapeutics market is dominated by leading players such as AbbVie, Amgen, Janssen Pharmaceuticals, and Pfizer.
USA – CANADA – UK – CHINA – INDIA
Key Buying Criteria
Guest Bloggers
• Authenticity • Delivery • Price• Service Support
Parameters Details
Affordability
Drugs used in the treatment of psoriasis should be affordable and priced
reasonably
Availability Drugs used in the treatment of psoriasis should be readily available in the
market
Efficacy Drugs used in the treatment of psoriasis should be efficient and show
positive results
Safety Drugs used in the treatment of psoriasis should be safe and have minimal
adverse effects
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
How would you like to engage with TechNavio?
Global Psoriasis Therapeutics Market
2015-2019
USA – CANADA – UK – CHINA – INDIA
Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps.Option to Customize Report & Access to Analysts on every Report Purchase.
Option to Customize Reports
Ask an Analyst
Or
Inform us by e-mailing
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making
purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of
or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION